Trial Profile
Atorvastatin +/- torcetrapib in patients with coronary artery disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2013
Price :
$35
*
At a glance
- Drugs Torcetrapib (Primary) ; Atorvastatin
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 01 Oct 2013 New trial record
- 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.